Literature DB >> 24445799

[INR Self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)].

H Körtke1, K Minami, T Breymann, D Seifert, A Baraktaris, O Wagner, G Kleikamp, A El-Banayosy, N Mirow, R Körfer.   

Abstract

Severe thromboembolic and hemorrhagic complications following mechanical heart valve replacement essentially occur due to intense oral anticoagulation and fluctuating individual INR values around the target range. INR self-management can help to minimize these fluctuations. Beginning this therapeutic control immediately after mechanical heart valve replacement further reduces anticoagulant-induced complications. Included in the study were 1200 patients. The quality of oral anticoagulation also improved through INR self-management. Over an observation period of two years, nearly 80 % of INR values recorded by the patients themselves were within the target therapeutic range of 2.5-4.5. This corresponds to a high significance of p < = 0.001 in favor of INR self-management. Only 64.9 % of INR values monitored by family practitioners were within the desired range. The results differed slightly in quality between patient groups with different levels of training (comprehensive, secondary modern, grammar with or without university). Of patients trained in INR self-management following mechanical heart valve replacement, 91.7 % maintained their competence in this technique throughout the entire follow-up period. Only 8.3 % of those trained immediately after surgery were unable to continue with INR self-management.

Entities:  

Year:  2001        PMID: 24445799     DOI: 10.1007/s003920170019

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  10 in total

1.  Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Second report of the Sixty Plus Reinfarction Study Research Group.

Authors: 
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

2.  Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting.

Authors:  F B Davis; M T Estruch; E B Samson-Corvera; G C Voigt; J D Tobin
Journal:  Arch Intern Med       Date:  1977-02

Review 3.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

Authors:  P D Stein; J S Alpert; J Copeland; J E Dalen; S Goldman; A G Turpie
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

4.  A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.

Authors:  J C Forfar
Journal:  Br Heart J       Date:  1979-08

Review 5.  Thrombotic and bleeding complications of prosthetic heart valves.

Authors:  L H Edmunds
Journal:  Ann Thorac Surg       Date:  1987-10       Impact factor: 4.330

6.  [Complications of anticoagulant treatment. Report of 98 accidents and incidents (author's transl)].

Authors:  G Gaudel; J Fouchard
Journal:  Sem Hop       Date:  1979 Sep 8-15

7.  A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease.

Authors:  K E Hammermeister; G K Sethi; W G Henderson; C Oprian; T Kim; S Rahimtoola
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

8.  Choosing a substitute cardiac valve: type, size, surgeon.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

9.  Problems encountered in long-term treatment with anticoagulants.

Authors:  S Husted; F Andreasen
Journal:  Acta Med Scand       Date:  1976

10.  Noninvasive radioisotopic technique for detection of platelet deposition in mitral valve prostheses and quantitation of visceral microembolism in dogs.

Authors:  M K Dewanjee; V Fuster; S A Rao; P L Forshaw; M P Kaye
Journal:  Mayo Clin Proc       Date:  1983-05       Impact factor: 7.616

  10 in total
  1 in total

Review 1.  Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation.

Authors:  Pawana Sharma; Graham Scotland; Moira Cruickshank; Emma Tassie; Cynthia Fraser; Christopher Burton; Bernard Croal; Craig R Ramsay; Miriam Brazzelli
Journal:  BMJ Open       Date:  2015-06-25       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.